HAPPINESS BIOTECH GROUP LTD (HAPP): Price and Financial Metrics


Today's Latest Price: $1.97 USD

0.01 (-0.51%)

Updated Nov 24 4:00pm

Add HAPP to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

HAPP Stock Summary

  • HAPP's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.47 -- higher than merely 6.08% of US-listed equities with positive expected earnings growth.
  • Happiness Biotech Group Ltd's stock had its IPO on October 25, 2019, making it an older stock than just 0.69% of US equities in our set.
  • With a price/earnings ratio of 3.76, Happiness Biotech Group Ltd P/E ratio is greater than that of about merely 2.86% of stocks in our set with positive earnings.
  • If you're looking for stocks that are quantitatively similar to Happiness Biotech Group Ltd, a group of peers worth examining would be UG, BHAT, GIGM, JOUT, and SCON.
  • Visit HAPP's SEC page to see the company's official filings. To visit the company's web site, go to www.happ.org.cn.

HAPP Stock Price Chart Interactive Chart >

Price chart for HAPP

HAPP Price/Volume Stats

Current price $1.97 52-week high $6.10
Prev. close $1.98 52-week low $1.63
Day low $1.89 Volume 867,000
Day high $2.04 Avg. volume 378,604
50-day MA $1.82 Dividend yield N/A
200-day MA $2.67 Market Cap 51.02M


Happiness Biotech Group Ltd. is a nutraceutical and dietary supplements producer, which engages in the research, development, manufacturing, marketing, and sales of a variety of products made from herbal and animal extracts. The firm's products include lucidum spore powder; cordyceps mycelia; ijiao solution; and American ginseng. It operates under the brand name Happiness. The company was founded on February 9, 2018 and is headquartered in Nanping City, China.

HAPP Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$1.97$0.86 -55%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Happiness Biotech Group Ltd. To summarize, we found that Happiness Biotech Group Ltd ranked in the 29th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 55%. As for the metrics that stood out in our discounted cash flow analysis of Happiness Biotech Group Ltd, consider:

  • The company's compound free cash flow growth rate over the past 1.08 years comes in at -0.23%; that's greater than only 6.61% of US stocks we're applying DCF forecasting to.
  • The business' balance sheet suggests that 4% of the company's capital is sourced from debt; this is greater than merely 14.08% of the free cash flow producing stocks we're observing.
  • The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than only 0% of stocks in its sector (Healthcare).

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

CDNA, JNJ, ZTS, HSIC, and IONS can be thought of as valuation peers to HAPP, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

HAPP Latest News Stream

Event/Time News Detail
Loading, please wait...

HAPP Latest Social Stream

Loading social stream, please wait...

View Full HAPP Social Stream

Latest HAPP News From Around the Web

Below are the latest news stories about Happiness Biotech Group Ltd that investors may wish to consider to help them evaluate HAPP as an investment opportunity.

Happiness Biotech launches $2.25M private support

Happiness Biotech ([[HAPP]] +15.5%) entered into a certain securities purchase agreement with three non-U.S. investors under which it has agreed to sell 900K ordinary shares at $2.5/share.Gross proceeds to be used for the development of Happy Buy's B2B e-Commerce business as well as for working capital and general corporate use."In addition to the capital,...

Seeking Alpha | September 25, 2020

Happiness Biotech Group Limited declares special dividend of $0.015

Happiness Biotech Group Limited (HAPP) declares $0.015/share special dividend.Payable Aug. 17; for shareholders of record Aug. 10; ex-div Aug. 7....

Seeking Alpha | July 31, 2020

Happiness Biotech Declares Special Cash Dividends to Shareholders

Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the Company has declared a cash dividend of $0.015 per ordinary share, payable in cash on or about August 17, 2020, to shareholders of record on August 10, 2020.

Yahoo | July 31, 2020

Happiness Biotech Announces Financial Results for Fiscal Year Ended March 31, 2020

Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, today announced its financial results for the fiscal year ended March 31, 2020.

Yahoo | July 24, 2020

Happiness Biotech Announced Receipt of NPN License in Canada for Its Hand Sanitizer

Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the 75% Alcohol Disposable Hand Sanitizer from the Company has successfully obtained Natural Product Number (NPN) license from Health Canada and the first order of 53,280 bottles have been shipped this week.

Yahoo | July 7, 2020

Read More 'HAPP' Stories Here

HAPP Price Returns

1-mo 12.57%
3-mo -9.22%
6-mo -23.64%
1-year -59.13%
3-year N/A
5-year N/A
YTD -56.75%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8989 seconds.